4-1BB-dependent inhibition of immunosuppression by activated CD4 +CD25+ T cells

Journal of Leukocyte Biology

Volumn 75, Issue 5, 2004, Pages 785-791

  Choi, Beom K ^a   Bae, Jun S ^a   Choi, Eun M ^a   Kang, Woo J ^a   Sakaguchi, Shimon ^b   Vinay, Dass S ^c   Kwon, Byoung S ^a,c  

^a University of Ulsan   (South Korea)

^b KYOTO UNIVERSITY   (Japan)

^c LSU EYE CENTER   (United States)

Author keywords

GVHD; Regulatory T lymphocytes; Suppression; Tolerance

Indexed keywords

CD137 ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

4-1BB LIGAND; ANIMALS; ANTIGENS, CD; ANTIGENS, CD137; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT VS HOST DISEASE; IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE TRANSFUSION; MICE; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-2; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 2342481815     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1003491     Document Type: Conference Paper

References (33)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
2. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296.
3. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169, 5401-5404.
4. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194, 629-644.
5. + immunoregulatory cells. J. Immunol. 167, 1137-1140.
6. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196, 237-246.
7. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3, 135-142.
8. Vinay, D. S., Kwon, B. S. (1998) Role of 4-1BB in immune responses. Semin. Immunol. 10, 481-489.
9. Melero, I., Johnston, J. V., Shuford, W. W., Mittler, R. S., Chen, L. (1998) NK 1.1 cells express 4-1BB (CDw137) costimulatory molecules and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell. Immunol. 190, 167-172.
10. Kwon, B., Moon, C. H., Seo, S. K., Kwon, B. S. (2000) 4-1BB: still in the midst of darkness. Mol. Cell 10, 119-126.
11. xL and Bfl-1. J. Immunol. 169, 4882-4888.
12. Miller, R. E., Jones, J., Le, T., Whitmore, J., Boiani, N., Gliniak, B., Lynch, D. H. (2002) 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner. J. Immunol. 169, 1792-1800.
13. Ye, Z., Hellstrom, I., Hayden-Ledbetter, M., Dahlin, A., Ledbetter, J. A., Hellstrom, K. E. (2002) Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. Nat. Med. 8, 343-348.
14. Wilcox, R. A., Flies, D. B., Zhu, G., Johnson, A. J., Tamada, K., Chapoval, A. I., Strome, S. E., Pease, L. R., Chen, L. (2002) Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J. Clin. Invest. 109, 651-659.
15. Kwon, B. S., Hurtado, J. C., Lee, Z. H., Kwack, K. B., Seo, S. K., Choi, B. K., Koller, B. H., Wolisi, G., Broxmeyer, H. E., Vinay, D. S. (2002) Immune responses in 4-1BB (CD137)-deficient mice. J. Immunol. 168, 5483-5490.
16. McHugh, R. S., Whitters, M. J., Piccirillo, C. A., Young, D. A., Shevach, E. M., Collins, M., Byrne, M. C. (2002) CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323.
17. + suppressor T cells in vivo. Nat. Immunol. 3, 33-41.
18. Pollok, K. E., Kim, Y. J., Zhou, Z., Hurtado, J. C., Kim, K. K., Pickard, R. T., Kwon, B. S. (1993) Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150, 771-781.
19. Croft, M. (2003) Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14, 265-273.
20. Cannons, J. L., Lau, P., Ghumman, B., DeBenedette, M. A., Yagita, H., Okumura, K., Watts, T. H. (2001) 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J. Immunol. 167, 1313-1324.
21. + cells. J. Exp. Med. 180, 307-317.
22. Blazar, B. R., Kwon, B. S., Panoskaltsis-Mortari, A., Kwak, K. B., Peschon, J. J., Taylor, P. A. (2001) Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J. Immunol. 166, 3174-3183.
23. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310.
24. Green, E. A., Choi, Y., Flavell, R. A. (2002) Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16, 183-191.
25. Akbari, O., Freeman, G. J., Meyer, E. H., Greenfield, E. A., Chang, T. T., Sharpe, A. H., Berry, G., DeKruyff, R. H., Umetsu, D. T. (2002) Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8, 1024-1032.
26. Taylor, P. A., Noelle, R. J., Blazar, B. R. (2001) CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193, 1311-1318.
27. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169, 6298-6308.
28. high regulatory cells in human peripheral blood. J. Immunol. 167, 1245-1253.
29. Bach, J. F. (2003) Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3, 189-198.
30. Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F., Wood, K. J. (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789-3796.
31. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080-1086.
32. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716.
33. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170, 394-399.